(Q43826988)

English

Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis

scientific article published in April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

steatohepatitis

0 references

toll-like receptor

0 references

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

author name string

Yusaku Shirai

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hitoshi Yoshiji

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ryuichi Noguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kosuke Kaji

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yosuke Aihara

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Akitoshi Douhara

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kei Moriya

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Tadashi Namisaki

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hideto Kawaratani

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hiroshi Fukui

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

723-730

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Toll-like receptors as targets in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Toll-like receptor signaling in the liver

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Toll-like receptors in the induction of the innate immune response

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

TLR4 enhances TGF-beta signaling and hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin II upregulates toll-like receptor 4 on mesangial cells

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Hepatocellular carcinoma arising in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Changes in the expression of angiotensin II type 1 receptor in the development of liver fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJGH.12112

21 January 2018

Identifiers

10.1111/JGH.12112

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43826988&oldid=2103694136"